Relationship of Mito‐Nuclear Genetics to FDG‐PET Alzheimer’s Disease Biomarkers in Aging

Abstract Background A growing amount of data has implicated the various roles of nuclear genes involved in mitochondrial function, and mitochondrial genes, on risk for Alzheimer’s disease (AD) and AD neuroimaging biomarkers. To date, no studies have investigated the relationship of mitochondrial haplogroups or the APOE and TOMM40 genes on brain glucose metabolism, a sensitive early marker of metabolic decline and possible mitochondrial dysfunction in AD. Method We analyzed regional standard uptake value ratio (SUVR) differences in 18F‐fluorodeoxyglucose positron emission tomography (FDG‐PET) using SPM12 and CAT12 software between nondemented (ND, n = 69), mild cognitively impaired (MCI, n = 19) and AD (n = 18) groups in a sample of individuals from the University of Kansas Alzheimer’s Disease Research Center Cohort, controlling for age, sex, and education. We then tested whether genetic variation in APOE (e4‐carriers vs. non‐carriers), TOMM40 rs2075650 (‘650 G‐allele carriers vs. A‐Allele) or mitochondrial haplogroup significantly influenced regional differences in glucose metabolism in nondemented individuals, as they made up the bulk of our sample of individuals with these scans. Result We found that, as expected, individuals with AD had significantly decreased glucose metabolism across all regions except the motor cortex and the cerebellum compared to ND individuals (Figure 1). Our results across various gene groups, controlling for age, sex, education, and with and without APOE e4 showed that there were no significant differences in FDG‐PET SUVR between ND TOMM40 ‘650 G‐allele carriers, or mitochondrial haplogroups (H, JT, and UK groups combined), however APOE e4‐carriers had significantly lower glucose metabolism in the anterior cingulate, superior medial frontal, posterior cingulate, medial frontal, right middle frontal, and bilateral superior frontal cortices than e4‐non carriers (Figure 2). There were no significant effects of APOE e4 on glucose metabolism in limbic regions. Conclusion The APOE e4 allele may have more impact on FDG‐PET in default mode regions (posterior and anterior cingulate, medial frontal cortex) than TOMM40 '650, a larger study in cognitively healthy individuals will be needed to confirm these results.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2024-12-01
DOI
https://doi.org/10.1002/alz.093820
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Relationship of Mito‐Nuclear Genetics to FDG‐PET Alzheimer’s Disease Biomarkers in Aging

Eric D. Vidoni, Jill K. Morris, Heather Wilkins, Russell Howard Swerdlow et al.
Alzheimer s & Dementia
Glioma Diagnosis and Treatment
article

Relationship of Mito‐Nuclear Genetics to FDG‐PET Alzheimer’s Disease Biomarkers in Aging

Eric D. Vidoni, Jill K. Morris, Heather Wilkins, Russell Howard Swerdlow, Jeffrey Murray Burns, Robyn A. Honea, Rebecca J. Lepping
article en

Abstract

Abstract Background A growing amount of data has implicated the various roles of nuclear genes involved in mitochondrial function, and mitochondrial genes, on risk for Alzheimer’s disease (AD) and AD neuroimaging biomarkers. To date, no studies have investigated the relationship of mitochondrial haplogroups or the APOE and TOMM40 genes on brain glucose metabolism, a sensitive early marker of metabolic decline and possible mitochondrial dysfunction in AD. Method We analyzed regional standard uptake value ratio (SUVR) differences in 18F‐fluorodeoxyglucose positron emission tomography (FDG‐PET) using SPM12 and CAT12 software between nondemented (ND, n = 69), mild cognitively impaired (MCI, n = 19) and AD (n = 18) groups in a sample of individuals from the University of Kansas Alzheimer’s Disease Research Center Cohort, controlling for age, sex, and education. We then tested whether genetic variation in APOE (e4‐carriers vs. non‐carriers), TOMM40 rs2075650 (‘650 G‐allele carriers vs. A‐Allele) or mitochondrial haplogroup significantly influenced regional differences in glucose metabolism in nondemented individuals, as they made up the bulk of our sample of individuals with these scans. Result We found that, as expected, individuals with AD had significantly decreased glucose metabolism across all regions except the motor cortex and the cerebellum compared to ND individuals (Figure 1). Our results across various gene groups, controlling for age, sex, education, and with and without APOE e4 showed that there were no significant differences in FDG‐PET SUVR between ND TOMM40 ‘650 G‐allele carriers, or mitochondrial haplogroups (H, JT, and UK groups combined), however APOE e4‐carriers had significantly lower glucose metabolism in the anterior cingulate, superior medial frontal, posterior cingulate, medial frontal, right middle frontal, and bilateral superior frontal cortices than e4‐non carriers (Figure 2). There were no significant effects of APOE e4 on glucose metabolism in limbic regions. Conclusion The APOE e4 allele may have more impact on FDG‐PET in default mode regions (posterior and anterior cingulate, medial frontal cortex) than TOMM40 '650, a larger study in cognitively healthy individuals will be needed to confirm these results.

Alzheimer s & DementiaVol. 20(S9)
University of Kansas (US), University of Kansas Medical Center (US), Imaging Center (US)
Openalex Percentile: Top 54%
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.